STAAR Surgical Q1 net sales up 119.6% to $93.5M; returns to profitability with GAAP EPS $0.10

STAAR SURGICAL CO

2026-Q1 EPS reported $0.10 vs consensus -$0.07 ▲ beat (+253.8%)

Record Q1 net sales of $93.5M, up 119.6% YoY, driven by China recovery and U.S. growth.
GAAP net income $5.2M ($0.10 diluted EPS) vs net loss of $54.2M ($1.10 loss) a year ago.
Adjusted EBITDA $24.4M ($0.48/share) vs adjusted EBITDA loss of $26.3M in prior year.
Gross margin improved to 73.6% from 65.8%; operating expenses down 18% YoY.
China distributor inventory normalized; EVO+ ICL launch early demand exceeded expectations.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

STAAR SURGICAL CO reported First Quarter 2026 results: revenue $93.5 million, net income $5.2 million, EPS $0.10.

Period: First Quarter 2026
Revenue: $93.5 million
Net income: $5.2 million
EPS: $0.10
Result: reported results

Exact text from the filing

STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter Net Sales of $93.5 million, highest first quarter Net Sales in Company’s history, up 119.6% Y/Y Net Income of $5.2 million, with GAAP EPS of $0.10

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

STAAR SURGICAL CO filing history →

Source: SEC EDGAR

accession 0000718937-26-000022

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.